Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, although the quality of findings may warrant future research.
New cases of COVID-19 are rising in all 50 states for the third consecutive day; stark increase in alcohol-associated liver disease hospitalizations reported amid the pandemic; nearly 2 dozen reports of mysterious health incidents have been observed among US personnel in Vienna, Austria.
Michael Thompson, president and chief executive officer of the National Alliance of Healthcare Purchaser Coalitions, speaks on the growth of telehealth and value-based care amid the COVID-19 pandemic, and the influence they will have on care delivery strategies in the years to come.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
Larger primary care practices in downside risk–only payment models and capitation saw the highest telemedicine utilization rates by their patients enrolled in Medicare Advantage (MA) plans.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor of neurology, Albert Einstein College of Medicine, addresses the treatment of narcolepsy in recent years.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Patients with Parkinson disease who participated in weekly dance training with music exhibited no decline in motor function and motor or nonmotor experiences of daily living across a 3-year span.
The new standards come as community oncology practices await word on the future of the oncology care model, which will expire in 2022.
HHS officials say that fully vaccinated individuals do not need to get a booster shot; FDA issues a warning on link between the Johnson & Johnson vaccine and a rare neurological condition; California counties sue pesticide manufacturer over widely used bug killer that may cause brain damage in children and fetuses.
The development of a successful gene therapy for RPE65-associated inherited retinal disease is a major breakthrough, but it also prompts difficult questions about which patients are good candidates for the therapy.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
New data underscore how obesity, racial disparities and recent treatment advancements have impacted cancer mortality and incidence rates.
This episode of Managed Care Cast features interviews with experts who discuss how the same efforts to stamp out COVID-19 also reduced Clostridioides difficile and the prospects for such mitigation efforts to continue.
Robin Gelburd, JD, details the dip in telehealth claims observed during April 2021.
The FDA issued a Complete Response Letter, halting Provention Bio's type 1 diabetes prevention drug.
Ambulance response services in rural communities face increasing recruitment and expense burdens; data from Israel show a decline in Pfizer/BioNTech COVID-19 vaccine efficacy in preventing symptomatic SARS-CoV-2 infection; the US Supreme Court will hear a case on 340B drug payment cuts.
Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist at Geisinger, discusses biologic, lifestyle, and pandemic-related factors associated with poor sleep quality in adolescents.
Health insurance companies are anticipating a swell in pent-up demand for delayed or forgone health services in 2020, as well as increased costs associated with distributing COVID-19 vaccines to millions of Americans. To offset the potentially precarious business impact caused by these converging factors, insurers are turning to technology for help.
Roundtable discussions between health care purchasers and physician practices highlight their aligned interest in having patients managed by a primary care physician, with other topics such as behavioral health, social determinants of health, and telehealth referenced as well.
A pharmacist-led collaborative medication management service reduced problems associated with polypharmacy in older adults with chronic kidney disease (CKD).
Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ever to address uncontrolled asthma head-on.
The measure is designed to end surprise medical billing and balance billing, taking the first step to implement the so-called No Surprises Act that passed Congress at the end of last year.
